0001415889-24-020202.txt : 20240726
0001415889-24-020202.hdr.sgml : 20240726
20240726174102
ACCESSION NUMBER: 0001415889-24-020202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240702
FILED AS OF DATE: 20240726
DATE AS OF CHANGE: 20240726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schiller Mark C.
CENTRAL INDEX KEY: 0002007659
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 241148212
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-07262024_090759.xml
X0508
4
2024-07-02
0001645666
Kezar Life Sciences, Inc.
KZR
0002007659
Schiller Mark C.
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Legal Officer
0
Common Stock
2024-07-02
4
S
0
6688
0.58
D
33007
D
Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
/s/ Marc Belsky, Attorney-in-Fact
2024-07-26